Revolution Medicines, Inc. (RVMDW) Free cash flow 2018–2025
Revolution Medicines, Inc. (RVMDW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$913.7MFY2025 · since FY2018: -$286,000 → -$913.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$913.7M | -60.9% |
| FY2024 | -$567.7M | -58.5% |
| FY2023 | -$358.3M | -52.3% |
| FY2022 | -$235.2M | -53.0% |
| FY2021 | -$153.7M | -49.2% |
| FY2020 | -$103.0M | -97.3% |
| FY2019 | -$52.2M | -18153.5% |
| FY2018 | -$286,000 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice